209 related articles for article (PubMed ID: 36326893)
1. Inhibition of the CCR6-CCL20 axis prevents regulatory T cell recruitment and sensitizes head and neck squamous cell carcinoma to radiation therapy.
Rutihinda C; Haroun R; Saidi NE; Ordoñez JP; Naasri S; Lévesque D; Boisvert FM; Fortier PH; Belzile M; Fradet L; Hubert-Tremblay V; Turgeon GA; Wang CS; Delage P; Rousseau É; Paquette B; Oweida AJ
Cancer Immunol Immunother; 2023 May; 72(5):1089-1102. PubMed ID: 36326893
[TBL] [Abstract][Full Text] [Related]
2. Targeting resistance to radiation-immunotherapy in cold HNSCCs by modulating the Treg-dendritic cell axis.
Knitz MW; Bickett TE; Darragh LB; Oweida AJ; Bhatia S; Van Court B; Bhuvane S; Piper M; Gadwa J; Mueller AC; Nguyen D; Nangia V; Osborne DG; Bai X; Ferrara SE; Boss MK; Goodspeed A; Burchill MA; Tamburini BAJ; Chan ED; Pickering CR; Clambey ET; Karam SD
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33883256
[TBL] [Abstract][Full Text] [Related]
3. Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis.
Chen KJ; Lin SZ; Zhou L; Xie HY; Zhou WH; Taki-Eldin A; Zheng SS
PLoS One; 2011; 6(9):e24671. PubMed ID: 21935436
[TBL] [Abstract][Full Text] [Related]
4. Regulation of CD4⁺FOXP3⁺ T cells by CCL20/CCR6 axis in early unexplained recurrent miscarriage patients.
Zhang XX; Kang XM; Zhao AM
Genet Mol Res; 2015 Aug; 14(3):9145-54. PubMed ID: 26345847
[TBL] [Abstract][Full Text] [Related]
5. STAT3 Modulation of Regulatory T Cells in Response to Radiation Therapy in Head and Neck Cancer.
Oweida AJ; Darragh L; Phan A; Binder D; Bhatia S; Mueller A; Court BV; Milner D; Raben D; Woessner R; Heasley L; Nemenoff R; Clambey E; Karam SD
J Natl Cancer Inst; 2019 Dec; 111(12):1339-1349. PubMed ID: 30863843
[TBL] [Abstract][Full Text] [Related]
6. The role of CCL20/CCR6 axis in recruiting Treg cells to tumor sites of NSCLC patients.
Zhang CY; Qi Y; Li XN; Yang Y; Liu DL; Zhao J; Zhu DY; Wu K; Zhou XD; Zhao S
Biomed Pharmacother; 2015 Feb; 69():242-8. PubMed ID: 25661365
[TBL] [Abstract][Full Text] [Related]
7. CCL20/CCR6-mediated migration of regulatory T cells to the Helicobacter pylori-infected human gastric mucosa.
Cook KW; Letley DP; Ingram RJ; Staples E; Skjoldmose H; Atherton JC; Robinson K
Gut; 2014 Oct; 63(10):1550-9. PubMed ID: 24436142
[TBL] [Abstract][Full Text] [Related]
8. CTL- vs Treg lymphocyte-attracting chemokines, CCL4 and CCL20, are strong reciprocal predictive markers for survival of patients with oesophageal squamous cell carcinoma.
Liu JY; Li F; Wang LP; Chen XF; Wang D; Cao L; Ping Y; Zhao S; Li B; Thorne SH; Zhang B; Kalinski P; Zhang Y
Br J Cancer; 2015 Sep; 113(5):747-55. PubMed ID: 26284335
[TBL] [Abstract][Full Text] [Related]
9. Complement C3a and C5a receptor blockade modulates regulatory T cell conversion in head and neck cancer.
Gadwa J; Bickett TE; Darragh LB; Knitz MW; Bhatia S; Piper M; Van Court B; Bhuvane S; Nguyen D; Nangia V; Kleczko EK; Nemenoff RA; Karam SD
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33789881
[TBL] [Abstract][Full Text] [Related]
10. The CCR6/CCL20 axis expands RORγt
Herrnstadt GR; Niehus CB; Ramcke T; Hagenstein J; Ehnold LI; Nosko A; Warkotsch MT; Feindt FC; Melderis S; Paust HJ; Sivayoganathan V; Jauch-Speer SL; Wong MN; Indenbirken D; Krebs CF; Huber TB; Panzer U; Puelles VG; Kluger MA; Steinmetz OM
Kidney Int; 2023 Jul; 104(1):74-89. PubMed ID: 36924892
[TBL] [Abstract][Full Text] [Related]
11. Tumor-Specific Antibody, Cetuximab, Enhances the
Jin WJ; Erbe AK; Schwarz CN; Jaquish AA; Anderson BR; Sriramaneni RN; Jagodinsky JC; Bates AM; Clark PA; Le T; Lan KH; Chen Y; Kim K; Morris ZS
Front Immunol; 2020; 11():591139. PubMed ID: 33281820
[TBL] [Abstract][Full Text] [Related]
12. PPARδ dysregulation of CCL20/CCR6 axis promotes gastric adenocarcinoma carcinogenesis by remodeling gastric tumor microenvironment.
Liu Y; Wei D; Deguchi Y; Xu W; Tian R; Liu F; Xu M; Mao F; Li D; Chen W; Valentin LA; Deguchi E; Yao JC; Shureiqi I; Zuo X
Gastric Cancer; 2023 Nov; 26(6):904-917. PubMed ID: 37572185
[TBL] [Abstract][Full Text] [Related]
13. Tumor-derived CCL20 affects B16 melanoma growth in mice.
Martin-Garcia D; Silva-Vilches C; Will R; Enk AH; Lonsdorf AS
J Dermatol Sci; 2020 Jan; 97(1):57-65. PubMed ID: 31883833
[TBL] [Abstract][Full Text] [Related]
14. In situ prior proliferation of CD4+ CCR6+ regulatory T cells facilitated by TGF-β secreting DCs is crucial for their enrichment and suppression in tumor immunity.
Xu L; Xu W; Wen Z; Xiong S
PLoS One; 2011; 6(5):e20282. PubMed ID: 21655250
[TBL] [Abstract][Full Text] [Related]
15. SMAD4 Suppresses Colitis-associated Carcinoma Through Inhibition of CCL20/CCR6-mediated Inflammation.
Hanna DN; Smith PM; Novitskiy SV; Washington MK; Zi J; Weaver CJ; Hamaamen JA; Lewis KB; Zhu J; Yang J; Liu Q; Beauchamp RD; Means AL
Gastroenterology; 2022 Nov; 163(5):1334-1350.e14. PubMed ID: 35863523
[TBL] [Abstract][Full Text] [Related]
16. CCL20, a direct-acting pro-angiogenic chemokine induced by hepatitis C virus (HCV): Potential role in HCV-related liver cancer.
Benkheil M; Van Haele M; Roskams T; Laporte M; Noppen S; Abbasi K; Delang L; Neyts J; Liekens S
Exp Cell Res; 2018 Nov; 372(2):168-177. PubMed ID: 30287142
[TBL] [Abstract][Full Text] [Related]
17. CCL20 blockade increases the severity of nephrotoxic folic acid-induced acute kidney injury.
González-Guerrero C; Morgado-Pascual JL; Cannata-Ortiz P; Ramos-Barron MA; Gómez-Alamillo C; Arias M; Mezzano S; Egido J; Ruiz-Ortega M; Ortiz A; Ramos AM
J Pathol; 2018 Oct; 246(2):191-204. PubMed ID: 29984403
[TBL] [Abstract][Full Text] [Related]
18. Enrichment of Human CCR6
Lee JJ; Kao KC; Chiu YL; Jung CJ; Liu CJ; Cheng SJ; Chang YL; Ko JY; Chia JS
J Immunol; 2017 Jul; 199(2):467-476. PubMed ID: 28600287
[TBL] [Abstract][Full Text] [Related]
19. The CCL20-CCR6 Axis in Cancer Progression.
Kadomoto S; Izumi K; Mizokami A
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32707869
[TBL] [Abstract][Full Text] [Related]
20. The CCR6/CCL20 axis mediates Th17 cell migration to the ocular surface in dry eye disease.
Dohlman TH; Chauhan SK; Kodati S; Hua J; Chen Y; Omoto M; Sadrai Z; Dana R
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4081-91. PubMed ID: 23702781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
